SCHEMBL844890

SCHEMBL844890

CC(C)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)C(C)C)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.51
CYP2C19 P33261 3/20 0.50
CYP2C9 P11712 2/20 0.49
NPC1 O15118 1/20 0.48
ALDH1A1 P00352 3/20 0.47
HTT P42858 2/20 0.47
MAPK1 P28482 2/20 0.47
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PABPC1 P11940 1/20 0.45
TSHR P16473 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844894 0.88 CYP2C19 (0.55) KCNH2CYP2C19CYP2C9NPC1ALDH1A1
SCHEMBL845599 0.87 RHOC (0.43) KCNH2CYP2C19CYP2C9NPC1ALDH1A1
SCHEMBL845488 0.86 CYP2C19 (0.48) KCNH2CYP2C19CYP2C9NPC1ALDH1A1
SCHEMBL845202 0.86 CYP2C19 (0.48) KCNH2CYP2C19CYP2C9NPC1ALDH1A1
SCHEMBL845759 0.86 CYP2C19 (0.48) KCNH2CYP2C19CYP2C9NPC1ALDH1A1
SCHEMBL845461 0.85 PREP (0.44) KCNH2CYP2C19CYP2C9NPC1LMNA
SCHEMBL845774 0.85 CYP2C19 (0.49) CYP2C19CYP2C9NPC1ALDH1A1HTT
SCHEMBL844977 0.84 MAPK1 (0.50) KCNH2CYP2C19CYP2C9ALDH1A1HTT
SCHEMBL845245 0.84 PTPN1 (0.50) KCNH2CYP2C19CYP2C9NPC1ALDH1A1
SCHEMBL845258 0.84 MAPK1 (0.60) KCNH2CYP2C19CYP2C9NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed